Statement on FDA's Approval of XENAZINE(R) for the Treatment of Chorea Associated With Huntington's Disease

NEW YORK, Aug. 15 /PRNewswire/ -- The Hereditary Disease Foundation (HDF) is extremely pleased the U.S. Food and Drug Administration has approved Xenazine, or tetrabenazine, for the treatment of chorea associated with Huntington's disease. "Chorea is a major cause of disability and death in ...

XENAZINE(R) (Tetrabenazine) Approved by FDA for Patients with Chorea Associated with Huntington's Disease

WASHINGTON, Aug. 15 /PRNewswire/ -- Prestwick Pharmaceuticals, Inc., a privately-held pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved XENAZINE(R) (tetrabenazine) for the treatment of chorea associated with Huntington's disease (HD). XENAZIN...

FDA Advisory Committee Votes Unanimously to Recommend Approval of Tetrabenazine for Chorea Associated With Huntington Disease

WASHINGTON, Dec. 6 /PRNewswire/ -- An advisory committee to the U.S. Food and Drug Administration (FDA) today voted unanimously to recommend the approval of tetrabenazine, which would be the first drug approved in the United States to treat chorea associated with Huntington disease (HD). "Th...

Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth

...holly owned subsidiary of Biovail Corp., marked the approval of the first-and-only medication available in the U.S. approved specifically for treating chorea associated with Huntington's disease (HD), a rare neurodegenerative disease affecting fewer than 25,000 Americans. From OVATION's prolific late-s...

S&R Communications Group Partners With Ovation Pharmaceuticals to Launch Xenazine* (tetrabenazine)

...mp;R Communications Group has entered a strategic partnership with Ovation Pharmaceuticals, Inc., to launch Xenazine* (tetrabenazine), a treatment for chorea associated with Huntington's disease (HD). Xenazine is the first and only FDA-approved treatment specifically developed for any HD-related symptom. ...

The First Treatment Specifically Approved for Huntington's Disease Patients is Now Available in the United States

... U.S. Food and Drug Administration (FDA) approved drug for the treatment of chorea associated with Huntington's Disease (HD), is now available in the United S...th chorea, a symptom present in an estimated 90 percent of people with HD. chorea is a debilitating movement disorder characterized by excessive, involuntary...

HDSA Applauds Announcement of the First Therapy to be Approved for the Specific Treatment of a Symptom of Huntington's Disease

... NEW YORK, Aug. 15 /PRNewswire/ -- The approval of Xenazine(R) (tetrabenazine), for the treatment of chorea associated with Huntington's Disease (HD), the first therapy to be approved specifically for the disease, is a significant milestone for all of our pa...

FDA approves first drug for Huntington's disease

...d in Europe, Canada and Australia to treat one of the most disabling symptoms of Huntington's disease, involuntary writhing movements known as chorea. chorea is one of the trademark symptoms of the disease, which directly affects about 30,000 people in the United States today; another 70,000 people who are ...

Alcohol Dehydrogenase Gene may Protect from Developing Alcoholism

...dividuals at high genetic risk for alcoholism can choose not to drink. There are no genes for alcohol dependence like there are genes for Huntington's chorea or other single-gene disorders. There are only genes that influence risk and protection for the disorder. While there have been a number of studies de...

Link Between Huntington’s and Abnormal Cholesterol Levels in Brain Establishe

...rray. “Fully understanding the mechanism of toxicity is the key to developing treatments.” Huntington’s disease -- sometimes called Huntington’s chorea or St. Vitus’ dance -- is a progressive, degenerative condition that causes nerve cells in the brain to waste away. Symptoms include uncontrolled move...

Chorea in Medical Technology

Clinical Trial Results Suggest Long-Term Treatment Benefit of Tetrabenazine for Chorea Associated with Huntington's Disease

BOSTON--(BUSINESS WIRE)--May 3, 2007 - New data show the investigational drug tetrabenazine maintained reduction of chorea associated with Huntington's disease (HD) up to 80 weeks in those patients who successfully completed treatment in a 13-week trial. These data suggest that tetrabenazine can be...

Chorea in Medical Dictionary

Chorea

Choreia (or chorea ) is an abnormal involuntary movement disorder, one of a group of neurological disorders called dyskinesias. The term choreia is derived from a Greek word χορεία ), as the quick movements of the feet or hands are vaguely comparable to dancing or piano... chorea n. Any of...

Petit mal seizure

..., prevention, and prognosis. Symptoms of Petit mal seizures including 12 medical symptoms ... All Online Books for Petit mal seizures . chorea (In a Page: Signs and Symptoms) ... ... types of seizures , including grand mal , absence, myoclonic, clonic, tonic, and atonic seizures . ... ...

Petit mal

...and prognosis. ... alternative diagnoses, misdiagnosis, and correct diagnosis for Petit mal ... All Online Books for Petit mal seizures. chorea (In a Page: Signs and Symptoms) ... A petit mal seizure is the term commonly given to a staring spell, most commonly called an ... Atypical ...

Athetosis

...oduction·Chorea, Athetosis , and Hemiballismus· Coordination Disorders ... chorea and athetosis , which may occur together as choreoathetosis, are not disor...dical abbreviations ... Tics, spasm, athetosis (slow, writhing motions), chorea (rapid, randomly ... Athetosis . Details. Comments. More from user. ...

Chorea in Biological Technology

Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer

... product candidate, tetrabenazine, a highly selective and reversible dopamine depletor in Phase 3 clinical trials for potential use as a treatment for chorea associated with Huntington's Disease. He joins Prestwick most recently from Zelos Therapeutics, where he was Executive Vice President of Development ...

Angel groups in Chicagoland beginning to sprout

...ty and spent a good portion of his life there. He finally died at age 55 on Oct. 3, 1967 at Creedmore State Hospital in Queens, N.Y. of Huntingtons chorea (a debilitative disease he had been diagnosed with 13 years earlier). Early in his career, Bob Dylan traveled to New York City from his native Minneso...